---
title: "$100 Invested In Revolution Medicines 5 Years Ago Would Be Worth This Much Today"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285961458.md"
description: "Revolution Medicines (NASDAQ:RVMD) has delivered an annualized return of 35.28% over the past 5 years, outperforming the market by 23.14%. With a current market cap of $30.17 billion, a $100 investment in RVMD five years ago would now be worth $471.42, highlighting the impact of compounded returns on investment growth."
datetime: "2026-05-11T14:15:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285961458.md)
  - [en](https://longbridge.com/en/news/285961458.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285961458.md)
---

# $100 Invested In Revolution Medicines 5 Years Ago Would Be Worth This Much Today

Revolution Medicines (NASDAQ:RVMD) has outperformed the market over the past 5 years by 23.14% on an annualized basis producing an average annual return of 35.28%. Currently, Revolution Medicines has a market capitalization of $30.17 billion.

**Buying $100 In RVMD:** If an investor had bought $100 of RVMD stock 5 years ago, it would be worth **$471.42** today based on a price of $141.92 for RVMD at the time of writing.

### Revolution Medicines's Performance Over Last 5 Years

![comp_fig](https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1778508922_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg)

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

_This article was generated by Benzinga's automated content engine and reviewed by an editor._

### Related Stocks

- [RVMD.US](https://longbridge.com/en/quote/RVMD.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [RVMDW.US](https://longbridge.com/en/quote/RVMDW.US.md)

## Related News & Research

- [Cancer Centers Race To Access Revolution Medicines' Pancreatic Cancer Treatment: Report](https://longbridge.com/en/news/286590889.md)
- [US Cancer Clinics Rush to Access Revolutionary Pancreatic Cancer Drug Daraxonrasib](https://longbridge.com/en/news/286405546.md)
- [US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug](https://longbridge.com/en/news/286394551.md)
- [A Look At Revolution Medicines (RVMD) Valuation After Daraxonrasib Expanded Access Approval](https://longbridge.com/en/news/285222043.md)
- [GraniteShares Files High-Octane 2X ETFs Tied To Nuclear, AI, Biotech Momentum Stocks](https://longbridge.com/en/news/286926662.md)